MedTrace Logo

ABSORB (Amount of Blueberries So Older Adults Reap Benefits)

NCT05937165 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2025-12-15

Study results available
· View outcomes & findings →

Summary

This randomized, cross-over, pilot study aims to compare preliminary impact of a standard dose of blueberry powder (24 g) vs a higher dose (48 g) on the bioavailability of flavonoids and inflammatory biomarkers in older adults with minor levels of depressive symptoms.

Conditions

  • Depressive Symptoms
  • Aging

Interventions

OTHER

Freeze-dried Blueberry Powder

Three day consumption of two doses of freeze-dried blueberry powder

Sponsors & Collaborators

  • Hebrew SeniorLife

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2024-11-25
Completion
2024-11-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05937165 on ClinicalTrials.gov